| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | synapse-associated extracellular matrix | 1.37e-04 | 13 | 168 | 3 | GO:0099535 | |
| GeneOntologyCellularComponent | extracellular matrix of synaptic cleft | 1.92e-04 | 3 | 168 | 2 | GO:0098965 | |
| GeneOntologyCellularComponent | tenascin complex | 3.81e-04 | 4 | 168 | 2 | GO:0090733 | |
| HumanPheno | Abnormal mitral valve morphology | FLNC DOHH RPS6KA3 DPYSL5 PPP1R13L CBS RYR1 PIK3R2 DCHS1 ADAMTS15 ANKRD11 ELN TNXB | 9.14e-06 | 257 | 62 | 13 | HP:0001633 |
| Domain | FN3 | 3.83e-05 | 185 | 164 | 9 | SM00060 | |
| Domain | - | A1BG NPHS1 PAPPA2 FLNC COL7A1 FN1 SGCA CADM4 TRIM3 FNDC1 CILP2 SIGIRR NCAN SIGLEC1 TNR TNXB CNTN1 | 7.67e-05 | 663 | 164 | 17 | 2.60.40.10 |
| Domain | FN3_dom | 9.82e-05 | 209 | 164 | 9 | IPR003961 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ABCC3 FLNC ANKS6 RAPGEF6 SETD1B KMT2B KIF26A MYO9B SREBF1 LAMA5 MCM5 TXNRD2 MAST2 CNTROB RYR1 ANO8 SLC52A3 ZGPAT DIP2A EHBP1L1 INF2 PLA2G4B GLI1 NBEAL2 MARK4 ANKRD34A ANKRD11 NINL COBL CACNA1H SH3BP5L SNX15 KIFC3 D2HGDH SMG6 RAB11FIP3 | 7.44e-20 | 1105 | 168 | 36 | 35748872 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NES RAPGEF6 CDC42EP4 MAP2 ARHGEF5 DPYSL5 SORBS1 BCAR1 MAST2 ARHGEF17 KIAA1671 DLC1 SAMD11 MARK4 ANKRD11 COBL SH3BP5L KLC3 | 2.19e-07 | 861 | 168 | 18 | 36931259 |
| Pubmed | 5.06e-07 | 14 | 168 | 4 | 23696835 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | FN1 KCTD13 PLEKHA4 LAMA5 APP PPP1R13L CNTROB CBS MOAP1 TRIM3 SAFB2 NINL COBL NOTCH3 | 6.52e-07 | 560 | 168 | 14 | 21653829 |
| Pubmed | 1.08e-06 | 214 | 168 | 9 | 22199357 | ||
| Pubmed | 1.10e-06 | 5 | 168 | 3 | 19357271 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | BDP1 CPAMD8 MAP2 DPYSL5 PEPD BCAR1 APP SHROOM2 ANO8 KIAA1671 PARP10 INF2 SIGIRR SPIN1 ANKRD11 ZFHX2 COBL CACNA1H SYTL1 NOTCH3 CPNE7 SMG6 | 3.25e-06 | 1489 | 168 | 22 | 28611215 |
| Pubmed | 3.59e-06 | 22 | 168 | 4 | 21513708 | ||
| Pubmed | alpha3beta1 Integrin is required for normal development of the epidermal basement membrane. | 3.82e-06 | 7 | 168 | 3 | 9151677 | |
| Pubmed | Myh10 deficiency leads to defective extracellular matrix remodeling and pulmonary disease. | 5.36e-06 | 52 | 168 | 5 | 30389913 | |
| Pubmed | Targeted Disruption of Mouse Dip2B Leads to Abnormal Lung Development and Prenatal Lethality. | 5.89e-06 | 53 | 168 | 5 | 33153107 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | BDP1 FN1 MAP2 DPYSL5 SORBS1 GPRIN1 DIP2A TRAFD1 NBEAL2 ANKRD11 COBL GALNT5 | 6.00e-06 | 497 | 168 | 12 | 36774506 |
| Pubmed | 6.09e-06 | 8 | 168 | 3 | 19651211 | ||
| Pubmed | NES FLNC FN1 KCTD13 ARHGAP23 MAP2 SYNE1 DPYSL5 SORBS1 MTHFS GRM2 ARHGEF17 SHROOM2 RTN1 TRIM3 DIP2A INF2 FGD4 NCAN TNR CNTN1 | 6.14e-06 | 1431 | 168 | 21 | 37142655 | |
| Pubmed | 6.23e-06 | 142 | 168 | 7 | 30232004 | ||
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | KCTD13 SYNE1 BACE1 APP SLC4A3 RTN1 ANO8 NRXN3 INF2 BAZ2A MDC1 MARK4 CACNA1H CNTN1 | 8.16e-06 | 697 | 168 | 14 | 28298427 |
| Pubmed | 1.09e-05 | 60 | 168 | 5 | 19075228 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 1.18e-05 | 363 | 168 | 10 | 14691545 | |
| Pubmed | 1.30e-05 | 10 | 168 | 3 | 16160063 | ||
| Pubmed | 1.78e-05 | 11 | 168 | 3 | 21228158 | ||
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 1.86e-05 | 168 | 168 | 7 | 30631154 | |
| Pubmed | High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface. | 2.01e-05 | 307 | 168 | 9 | 37499664 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 27687728 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 9245798 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 32029735 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 7963647 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 17546051 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 9922219 | ||
| Pubmed | Maternal surfactant protein A influences the immunoprotective properties of milk in a murine model. | 2.32e-05 | 2 | 168 | 2 | 24858142 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 10406848 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 24954098 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 23931995 | ||
| Pubmed | Surfactant protein A modulates neuroinflammation in adult mice upon pulmonary infection. | 2.32e-05 | 2 | 168 | 2 | 38964703 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 34917085 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 22219327 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 15890661 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 15385504 | ||
| Pubmed | A TLR4-interacting SPA4 peptide inhibits LPS-induced lung inflammation. | 2.32e-05 | 2 | 168 | 2 | 23475791 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 23038062 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 20127045 | ||
| Pubmed | APP knockout mice experience acute mortality as the result of ischemia. | 2.32e-05 | 2 | 168 | 2 | 22912719 | |
| Pubmed | The in vivo dynamic interplay of MDC1 and 53BP1 at DNA damage-induced nuclear foci. | 2.32e-05 | 2 | 168 | 2 | 22677490 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 19074428 | ||
| Pubmed | BACE1 Mediates HIV-Associated and Excitotoxic Neuronal Damage Through an APP-Dependent Mechanism. | 2.32e-05 | 2 | 168 | 2 | 29632166 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 29394894 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 37735673 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 17307210 | ||
| Pubmed | Surfactant protein A modulates induction of regulatory T cells via TGF-β. | 2.32e-05 | 2 | 168 | 2 | 22474025 | |
| Pubmed | Surfactant protein A promotes western diet-induced hepatic steatosis and fibrosis in mice. | 2.32e-05 | 2 | 168 | 2 | 38553537 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 31513457 | ||
| Pubmed | Surfactant protein A reduces TLR4 and inflammatory cytokine mRNA levels in neonatal mouse ileum. | 2.32e-05 | 2 | 168 | 2 | 33510368 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 21500352 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 19392648 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 25481013 | ||
| Pubmed | Surfactant protein A suppresses lipopolysaccharide-induced IL-10 production by murine macrophages. | 2.32e-05 | 2 | 168 | 2 | 11342662 | |
| Pubmed | Surfactant protein A-deficient mice are susceptible to group B streptococcal infection. | 2.32e-05 | 2 | 168 | 2 | 9126996 | |
| Pubmed | A mutation in APP protects against Alzheimer's disease and age-related cognitive decline. | 2.32e-05 | 2 | 168 | 2 | 22801501 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 26758378 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 35076977 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 2050021 | ||
| Pubmed | Functions of Aβ, sAPPα and sAPPβ : similarities and differences. | 2.32e-05 | 2 | 168 | 2 | 22150401 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 25171714 | ||
| Pubmed | Gene expression profiles of APP and BACE1 in Tg SOD1G93A cortical cells. | 2.32e-05 | 2 | 168 | 2 | 19214738 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 19372755 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 26401691 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 18986980 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 19335775 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 12922979 | ||
| Pubmed | Differences in the alveolar macrophage toponome in humanized SP-A1 and SP-A2 transgenic mice. | 2.32e-05 | 2 | 168 | 2 | 33141765 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 16009723 | ||
| Pubmed | NFkappaB-dependent control of BACE1 promoter transactivation by Abeta42. | 2.32e-05 | 2 | 168 | 2 | 18263584 | |
| Pubmed | Innate immunity of surfactant protein A in experimental otitis media. | 2.32e-05 | 2 | 168 | 2 | 31378117 | |
| Pubmed | Altered amyloid-beta metabolism and deposition in genomic-based beta-secretase transgenic mice. | 2.32e-05 | 2 | 168 | 2 | 15452128 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 11237812 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 8207383 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 27916681 | ||
| Pubmed | Surfactant protein A inhibits alveolar macrophage cytokine production by CD14-independent pathway. | 2.32e-05 | 2 | 168 | 2 | 12959932 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 15044702 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 1986781 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 12740217 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 18083768 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 22985576 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 24613671 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 9081628 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 35322074 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 25147112 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 9700084 | ||
| Pubmed | Novel role for surfactant protein A in gastrointestinal graft-versus-host disease. | 2.32e-05 | 2 | 168 | 2 | 22508928 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 20963503 | ||
| Pubmed | Genetic and pharmacological evidence of intraneuronal Abeta accumulation in APP transgenic mice. | 2.32e-05 | 2 | 168 | 2 | 19683527 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 25605768 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 12959946 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 25976740 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 10531052 | ||
| Pubmed | Major Effect of Oxidative Stress on the Male, but Not Female, SP-A1 Type II Cell miRNome. | 2.32e-05 | 2 | 168 | 2 | 31354704 | |
| Pubmed | Signaling Pathways That Mediate Alveolar Macrophage Activation by Surfactant Protein A and IL-4. | 2.32e-05 | 2 | 168 | 2 | 35444643 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 20833873 | ||
| Pubmed | Lysophosphatidic acid induces increased BACE1 expression and Aβ formation. | 2.32e-05 | 2 | 168 | 2 | 23036978 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 24361992 | ||
| Pubmed | Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo. | 2.32e-05 | 2 | 168 | 2 | 10749762 | |
| Interaction | TOP3B interactions | ABCC3 FLNC ANKS6 RAPGEF6 SETD1B KMT2B KIF26A MYO9B PLEKHA4 SREBF1 LAMA5 MCM5 TXNRD2 APP MAST2 CNTROB RYR1 ANO8 SLC52A3 ZGPAT DIP2A EHBP1L1 INF2 PLA2G4B GLI1 NBEAL2 MDC1 MARK4 ANKRD34A ANKRD11 SAFB2 NINL COBL CACNA1H SH3BP5L SNX15 KIFC3 D2HGDH TP53BP1 SMG6 RAB11FIP3 | 2.07e-12 | 1470 | 165 | 41 | int:TOP3B |
| Interaction | NEFL interactions | 8.64e-07 | 161 | 165 | 10 | int:NEFL | |
| Interaction | YWHAG interactions | RAPGEF6 FN1 KCTD13 ARHGAP23 MAP2 ARHGEF5 RPS6KA3 DPYSL5 PLEKHA4 MCM5 SORBS1 BCAR1 APP MAST2 ARHGEF17 SHROOM2 KIAA1671 TTBK1 DLC1 SAMD11 MARK4 ANKRD34A ANKRD11 NINL COBL SH3BP5L KLC3 | 3.33e-06 | 1248 | 165 | 27 | int:YWHAG |
| Interaction | TNR interactions | 1.40e-05 | 38 | 165 | 5 | int:TNR | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | CPAMD8 DOHH MYO9B PLK5 ANO8 CILP2 PIK3R2 NCAN SAFB2 NOTCH3 SMIM44 | 1.85e-04 | 797 | 168 | 11 | chr19p13 |
| GeneFamily | Fibronectin type III domain containing | 6.94e-05 | 160 | 114 | 7 | 555 | |
| GeneFamily | Immunoglobulin like domain containing | 1.41e-03 | 193 | 114 | 6 | 594 | |
| GeneFamily | Collectins | 1.72e-03 | 10 | 114 | 2 | 491 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 2.04e-03 | 40 | 114 | 3 | 592 | |
| GeneFamily | Paraneoplastic Ma antigens | 2.09e-03 | 11 | 114 | 2 | 671 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 2.19e-03 | 41 | 114 | 3 | 1298 | |
| GeneFamily | ATP binding cassette subfamily C | 2.94e-03 | 13 | 114 | 2 | 807 | |
| GeneFamily | Endogenous ligands | 3.92e-03 | 237 | 114 | 6 | 542 | |
| GeneFamily | Ankyrin repeat domain containing | 4.33e-03 | 242 | 114 | 6 | 403 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 4.55e-03 | 53 | 114 | 3 | 532 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 3.03e-07 | 23 | 167 | 5 | M48001 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | CDC42EP4 HK3 KCTD13 MYO9B SREBF1 TXNRD2 GRAMD4 PARP10 DIP2A EHBP1L1 KLF13 PLA2G4B PIK3R2 MDC1 LRCH4 ANKRD11 SAFB2 D2HGDH PNMA3 | 5.49e-06 | 905 | 167 | 19 | M40865 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | FLNC COL7A1 CDC42EP4 HK3 FN1 CADM4 PYY MAST2 ARHGEF17 RTN1 EHBP1L1 TRAFD1 NINL ZFHX2 CACNA1H ELN TNXB SLC16A8 NOTCH3 | 5.85e-06 | 909 | 167 | 19 | M41018 |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | PAPPA2 KMT2B KIAA1671 PARP10 BAZ2A FGD4 ANKRD11 SAFB2 KIFC3 CNTN1 SMG6 RAB11FIP3 | 1.60e-05 | 417 | 167 | 12 | M39224 |
| Coexpression | YOSHIMURA_MAPK8_TARGETS_UP | OLAH CEBPE KCTD13 MAP2 BCAR1 PPP1R13L CBS SLC4A3 RTN1 TGFBR3 DLC1 PTPRN INF2 FGD4 NCAN DCHS1 SFTPA1 CACNA1H GALNT5 TNR TNXB CNTN1 | 2.28e-05 | 1281 | 167 | 22 | M1884 |
| Coexpression | GSE3982_BASOPHIL_VS_EFF_MEMORY_CD4_TCELL_DN | 3.89e-05 | 196 | 167 | 8 | M5557 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 4.33e-05 | 199 | 167 | 8 | M5893 | |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_DN | 4.49e-05 | 200 | 167 | 8 | M7323 | |
| Coexpression | GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4MID_BCELL_UP | 4.49e-05 | 200 | 167 | 8 | M9840 | |
| Coexpression | GSE36078_UNTREATED_VS_AD5_INF_MOUSE_LUNG_DC_UP | 4.49e-05 | 200 | 167 | 8 | M9289 | |
| Coexpression | NABA_CORE_MATRISOME | 6.20e-05 | 270 | 167 | 9 | MM17057 | |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | KCTD13 MYO9B CNTROB GRAMD4 SLC52A3 KAT8 LRCH4 SAFB2 SH3BP5L HSF4 | 6.59e-05 | 338 | 167 | 10 | M17094 |
| Coexpression | NABA_CORE_MATRISOME | 7.14e-05 | 275 | 167 | 9 | M5884 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 3.97e-06 | 118 | 165 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K3 | |
| ToppCell | COPD-Stromal-SMC|COPD / Disease state, Lineage and Cell class | 1.69e-09 | 179 | 168 | 10 | 5c705627bd13a5b2c7b0062fb3d94e4eb1589327 | |
| ToppCell | COPD-Stromal-SMC|World / Disease state, Lineage and Cell class | 1.69e-09 | 179 | 168 | 10 | b2709537ec1b46457ab85261f4cdd354e60a8b29 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.85e-09 | 189 | 168 | 10 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.25e-09 | 197 | 168 | 10 | 16758f181ef07c60aee63072e1da9572c5c85414 | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | FLNC SGCA SORBS1 ARHGEF17 HRC LMOD1 CACNA1H ELN MOCS1 NOTCH3 | 4.46e-09 | 198 | 168 | 10 | 705118a5db366b43ffd3389c60e4cb392ad3f2e6 |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.46e-09 | 198 | 168 | 10 | 1e1ea54f0c234f3b6d29064c4881d8a0c0949a75 | |
| ToppCell | Adult|World / Lineage, Cell type, age group and donor | 4.48e-08 | 189 | 168 | 9 | 5cd285bfad973125d46d704fec18b21266a63379 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.68e-08 | 190 | 168 | 9 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | CPAMD8 MAP2 LAMA5 ARHGEF17 DLC1 ST8SIA6 CACNA1H MOCS1 NOTCH3 | 4.68e-08 | 190 | 168 | 9 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.68e-08 | 190 | 168 | 9 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | IPF-Stromal-Pericyte|World / Disease state, Lineage and Cell class | 5.60e-08 | 194 | 168 | 9 | 1a41da29d5adaf766a84eff0003b959e4523f7f1 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.97e-08 | 199 | 168 | 9 | 9a08c25bb4851ad4ac9db8916422280f71378c2c | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.97e-08 | 199 | 168 | 9 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Myofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.97e-08 | 199 | 168 | 9 | 534dcfe8b65ad92bb8d749d1c7036ad4807e09cd | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.97e-08 | 199 | 168 | 9 | 2ed10c5e15c9d5ed0a8bea580842348d5698a07b | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.27e-08 | 200 | 168 | 9 | b441b3771fb7d9ee7b7a104afc35e466aace2da2 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-07 | 171 | 168 | 8 | b54d9d6b03c9c6f28a71cf2ed2bfa9a335bba949 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-07 | 171 | 168 | 8 | 9d825a2e799421af4f2cf4f4dc8e239b5d00476d | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.65e-07 | 176 | 168 | 8 | 852d3da0907fe87c0ef23d75a63ce07619cf0c54 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.65e-07 | 176 | 168 | 8 | d2df1e435996c51213e88270af9f928e9e09a6f5 | |
| ToppCell | Control-Stromal-SMC|Control / Disease state, Lineage and Cell class | 4.15e-07 | 179 | 168 | 8 | 1378051bc62009eec2dbecf3d5d89baedbeb84eb | |
| ToppCell | Bronchial_Biopsy-Mesenchymal-Smooth_muscle|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.33e-07 | 180 | 168 | 8 | 7085a851807e6a833965e1366946db0bbc5174e2 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.51e-07 | 181 | 168 | 8 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | RA-07._Pericyte|World / Chamber and Cluster_Paper | 4.71e-07 | 182 | 168 | 8 | 2075efeae633550fb2eb026d0dfd741c8252482e | |
| ToppCell | Pericytes-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 5.78e-07 | 187 | 168 | 8 | 35f25780d113f60bf4c13749013c09612ee4ff41 | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial-Cd36+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.02e-07 | 188 | 168 | 8 | e901a9bdf00b8e91806f445af66647373bf62661 | |
| ToppCell | IPF-Stromal-SMC|World / Disease state, Lineage and Cell class | 6.02e-07 | 188 | 168 | 8 | b66264e8f8d536ed2beec31e6746c687718f239b | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.02e-07 | 188 | 168 | 8 | 340f0e3e65c7a00d82d26621ff37107458bebc41 | |
| ToppCell | normal_Lung-Fibroblasts-Smooth_muscle_cells|normal_Lung / Location, Cell class and cell subclass | 6.02e-07 | 188 | 168 | 8 | fd70fb89570f014d1299c60fe017dc09f24e57c6 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.02e-07 | 188 | 168 | 8 | 9d384c0934f1461bc37b1f83e0877d7bee2116ee | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.02e-07 | 188 | 168 | 8 | 5cf060bb8adaefa9964187195d67993c1248ef47 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.02e-07 | 188 | 168 | 8 | a5e7a363fbd5ae4d9312cf6f9941413d6a5c0b4d | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-smooth_muscle_cell_of_trachea|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.02e-07 | 188 | 168 | 8 | 794fc1d9a726945c42f7eac221eed938309b47a9 | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.02e-07 | 188 | 168 | 8 | 449f9602df3c83b2110eb479a00d428d1b55b423 | |
| ToppCell | IPF-Stromal-SMC|IPF / Disease state, Lineage and Cell class | 6.02e-07 | 188 | 168 | 8 | e98b24c0de41285f01f7ac194ff0a1b59fd5c333 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.26e-07 | 189 | 168 | 8 | 7fbe855bfdb47d35e040b04a80fe4b729a3764e8 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.26e-07 | 189 | 168 | 8 | 975e7aa3b862a8b07c2ab8426a14f5cc54998aca | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.26e-07 | 189 | 168 | 8 | 06b35abecd29f902cf251fcc1f6ad33db7ab08a2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.26e-07 | 189 | 168 | 8 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.26e-07 | 189 | 168 | 8 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.52e-07 | 190 | 168 | 8 | e04f47705851563515b6a66a2634cf7a574f7bda | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-07 | 191 | 168 | 8 | 8e8beb8e8a3b33cac83d3f7ce915a71e3654fdab | |
| ToppCell | droplet-Trachea-3m-Epithelial-airway_epithelial-neuroendocrine_cell-neuroendocrine|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.78e-07 | 191 | 168 | 8 | 72f1ddc09080dbfea8d51294cbf7f9d4925f9cc0 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.78e-07 | 191 | 168 | 8 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | droplet-Trachea-3m-Epithelial-airway_epithelial-neuroendocrine_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.78e-07 | 191 | 168 | 8 | 6e7f589efc997f32175e0789c5ea7ca46e1389b8 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.78e-07 | 191 | 168 | 8 | 9032aa974aa1b7b1095b8d1b58dcb087358a5001 | |
| ToppCell | droplet-Trachea-nan-3m-Epithelial-neuroendocrine_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-07 | 191 | 168 | 8 | 3ce403e0beedb544edeb3ae6eb30267040d00c21 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.78e-07 | 191 | 168 | 8 | 5717809a1476c20f65bce722c5a57cff92ee0d7a | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Smooth_muscle|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.34e-07 | 193 | 168 | 8 | 9104b572d9c3c99080e4b7455993fbb944bf117d | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.63e-07 | 194 | 168 | 8 | 8fae8061b350336299aa81f378e07deadbd55123 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.63e-07 | 194 | 168 | 8 | 4d7d24390fdb379f943ddcc70a63f23955e10163 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.63e-07 | 194 | 168 | 8 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.93e-07 | 195 | 168 | 8 | e10b21e4dba4483efc4c82d6e395524246ca14a8 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.93e-07 | 195 | 168 | 8 | 24d226f89dd337c22728688e4b40ca082a0e1fe1 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.93e-07 | 195 | 168 | 8 | f5e91ce20a7ce528dc4c1a968c7bf096bf45c528 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-K_(Pericytes)|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.24e-07 | 196 | 168 | 8 | a5cc4f76e1a3825aaccba9a686d7da6f7e4300ff | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.24e-07 | 196 | 168 | 8 | b8759e6231e0254797d6c30930407b79440c57bb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.24e-07 | 196 | 168 | 8 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.24e-07 | 196 | 168 | 8 | 9d7b631f24a19a7dc7a28f28525d4019fc8fcf8a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.24e-07 | 196 | 168 | 8 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-K_(Pericytes)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.24e-07 | 196 | 168 | 8 | 476812fc1422aca8010d771eff11fa6081f15a2d | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.24e-07 | 196 | 168 | 8 | 208ddedd29e1b9ca89cbb9b527c2e193a44cada2 | |
| ToppCell | IPF-Stromal-Pericyte|IPF / Disease state, Lineage and Cell class | 8.24e-07 | 196 | 168 | 8 | 8b6ff47ce5291d223f5e639fc45cd9267f418256 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.24e-07 | 196 | 168 | 8 | 12d9028f90c057c6e5cff00301793fa550e86c5a | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.56e-07 | 197 | 168 | 8 | 7d97c2d51a543c02d679e9257b22d0581e73a11d | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.56e-07 | 197 | 168 | 8 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | Bronchial_Biopsy-Mesenchymal-Smooth_muscle|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.56e-07 | 197 | 168 | 8 | 98f0184a09563a544f0c2d4df22c9db2fbc95019 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.56e-07 | 197 | 168 | 8 | 671d6b5effbac2dd71d18f48d23c523738db1828 | |
| ToppCell | distal-mesenchymal-Vascular_Smooth_Muscle-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.56e-07 | 197 | 168 | 8 | da653dc7d216e202f390e5ab0245f243e3ed213b | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.56e-07 | 197 | 168 | 8 | d16bb765afdc02406ffd7ce6a75bae72b66db66c | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.56e-07 | 197 | 168 | 8 | 68c23c23b6924892f4c238cf2f5abc7927e04fbc | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.89e-07 | 198 | 168 | 8 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | 5'-Adult-Distal_Rectal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.89e-07 | 198 | 168 | 8 | db26c20321f9ab102d6484f22ddb2bde684067b1 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-K_(Pericytes)|390C / Donor, Lineage, Cell class and subclass (all cells) | 8.89e-07 | 198 | 168 | 8 | c82a151f9f1477d4a401457173b8d72af776c137 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-K_(Pericytes)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 8.89e-07 | 198 | 168 | 8 | dc63b56bb6291e527b172d603569376286262845 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.24e-07 | 199 | 168 | 8 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.24e-07 | 199 | 168 | 8 | 056a28c36cd58dc695a5ae6f29b62135d6aad819 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.24e-07 | 199 | 168 | 8 | 8ff0fdcbe9661b013913731ec8b53d84836ca865 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.24e-07 | 199 | 168 | 8 | 20f760d92c351a1dac4cc0a424c443ea03a179fe | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.24e-07 | 199 | 168 | 8 | ad75e5e26c37a97331164d7f77235ebd9a933a44 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.24e-07 | 199 | 168 | 8 | 7c272a1aa7f3e931ad5d20809719d85b3bce4cb0 | |
| ToppCell | distal-2-mesenchymal-Airway_Smooth_Muscle|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.24e-07 | 199 | 168 | 8 | af226a6c50747dad9ca696463e715913b3ac17c0 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.24e-07 | 199 | 168 | 8 | b1753474152b82a0b811b9878c890a359e14919a | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.59e-07 | 200 | 168 | 8 | 12326cc6f0af24bacba9493dc79e7c7347db2f41 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 9.59e-07 | 200 | 168 | 8 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.59e-07 | 200 | 168 | 8 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.59e-07 | 200 | 168 | 8 | 362706445edb33b313684efe50b1f44f5f816e67 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.59e-07 | 200 | 168 | 8 | f9bc22ff17bb1c751e6b05bca3f403836f33459a | |
| ToppCell | Parenchymal-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.59e-07 | 200 | 168 | 8 | 0a7640db28c708003d5da2d19eb651f6fedfd710 | |
| ToppCell | LPS_only-Mesenchymal_myocytic|LPS_only / Treatment groups by lineage, cell group, cell type | 9.59e-07 | 200 | 168 | 8 | 8bc9923f82bfb836e2f524204c92050edeae8ca5 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.80e-06 | 162 | 168 | 7 | 68c40d12689cc1b6c797e6e48173f0110f8144e4 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.80e-06 | 162 | 168 | 7 | 735fa3f77b31a4189e431d05c326403c18cbbffb | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.56e-06 | 168 | 168 | 7 | 0f736d58cb0ff042fa3ce58e36bde37b6976f8fc | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.32e-06 | 173 | 168 | 7 | 5c55e1e27e9e3e77600d378cc87b51cc73907527 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.49e-06 | 174 | 168 | 7 | 778e0317c0c63fa4efd74114feb760975b819d92 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.49e-06 | 174 | 168 | 7 | 4da79da7a09ee1e345102c5331675ebcdbe56171 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.66e-06 | 175 | 168 | 7 | 12f5fd83c7710fc0c77406f765d9cbd133433b8b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.66e-06 | 175 | 168 | 7 | d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.66e-06 | 175 | 168 | 7 | 454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.74e-06 | 114 | 168 | 6 | 108cc5b04cc7c59310eb55dc2c44ae2b8e0b05e4 | |
| Computational | Heparin binding. | 1.17e-04 | 28 | 99 | 4 | MODULE_385 | |
| Drug | radicicol; Down 200; 0.1uM; PC3; HG-U133A | ABCC3 KMT2B SREBF1 MCM5 EHBP1L1 TRAFD1 PTPRN BAZ2A GDF11 NOTCH3 | 2.11e-06 | 199 | 166 | 10 | 484_DN |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; PC3; HT_HG-U133A | 1.07e-05 | 189 | 166 | 9 | 3733_DN | |
| Drug | 5230742; Up 200; 17uM; MCF7; HT_HG-U133A_EA | 1.11e-05 | 190 | 166 | 9 | 970_UP | |
| Drug | colchicine; Up 200; 1uM; SKMEL5; HG-U133A | 1.11e-05 | 190 | 166 | 9 | 630_UP | |
| Drug | Xylazine [7361-61-7]; Down 200; 18.2uM; PC3; HT_HG-U133A | 1.49e-05 | 197 | 166 | 9 | 4066_DN | |
| Drug | Natamycin [7681-93-8]; Down 200; 6uM; MCF7; HT_HG-U133A | 1.68e-05 | 200 | 166 | 9 | 7167_DN | |
| Drug | Austricine [10180-88-8]; Down 200; 14.2uM; HL60; HT_HG-U133A | 1.68e-05 | 200 | 166 | 9 | 2157_DN | |
| Disease | Colorectal Carcinoma | ABCC3 ABCC1 FLNC COL7A1 CPAMD8 HK3 FN1 MAP2 SYNE1 KCNH4 ZNHIT6 DLC1 DCHS1 ADAMTS15 CNTN1 | 8.23e-06 | 702 | 162 | 15 | C0009402 |
| Disease | neutrophil count | PAPPA2 NES CPAMD8 CEBPE ARHGAP23 PEPD MAST2 CBS CREB5 ZGPAT DIP2A TRAFD1 PRPF4 NBEAL2 MARK4 MIPEP ANKRD34A ANKRD11 TNR TNXB SMG6 | 2.40e-05 | 1382 | 162 | 21 | EFO_0004833 |
| Disease | pulse pressure measurement | PAPPA2 FN1 PEPD PYY LAMA5 BCAR1 MAST2 CREB5 KCNH4 TGFBR3 FCSK DIP2A FNDC1 CILP2 TTBK1 DLC1 ADAMTS15 ANKRD11 ELN NOTCH3 SMG6 | 2.66e-05 | 1392 | 162 | 21 | EFO_0005763 |
| Disease | glucose-dependent insulinotropic peptide measurement, glucose tolerance test | 5.66e-05 | 14 | 162 | 3 | EFO_0004307, EFO_0008464 | |
| Disease | Malignant neoplasm of breast | ABCC1 COL7A1 HK3 FN1 SYNE1 RPS6KA3 SORBS1 BCAR1 SHROOM2 CLCA2 GLI1 ANKRD34A GALNT5 PCDH8 NOTCH3 TP53BP1 | 2.95e-04 | 1074 | 162 | 16 | C0006142 |
| Disease | level of leukocyte immunoglobulin-like receptor subfamily B member 4 in blood serum | 2.96e-04 | 5 | 162 | 2 | OBA_2042200 | |
| Disease | level of prosaposin in blood serum | 2.96e-04 | 5 | 162 | 2 | OBA_2044552 | |
| Disease | congenital diaphragmatic hernia (biomarker_via_orthology) | 3.02e-04 | 24 | 162 | 3 | DOID:3827 (biomarker_via_orthology) | |
| Disease | serum alanine aminotransferase measurement | RAPGEF6 PEPD LAMA5 TP53INP2 CREB5 FCSK ZGPAT CILP2 TRAFD1 KLF13 PIK3R2 NCAN MARK4 USP35 | 3.29e-04 | 869 | 162 | 14 | EFO_0004735 |
| Disease | Schizophrenia | A1BG RAPGEF6 MYO9B ACSM1 SREBF1 BACE1 GRM2 CBS NRXN3 PLA2G4B KAT8 NCAN PCDH8 TNXB | 3.85e-04 | 883 | 162 | 14 | C0036341 |
| Disease | sexual dimorphism measurement | PAPPA2 COL7A1 RAPGEF6 KMT2B KCTD13 MYO9B BACE1 TP53INP2 CREB5 ZGPAT PARP10 EHBP1L1 NRXN3 ANKRD11 SMIM44 TP53BP1 | 4.07e-04 | 1106 | 162 | 16 | EFO_0021796 |
| Disease | Abnormality of vision | 4.43e-04 | 6 | 162 | 2 | C4025846 | |
| Disease | newborn respiratory distress syndrome (biomarker_via_orthology) | 4.43e-04 | 6 | 162 | 2 | DOID:12716 (biomarker_via_orthology) | |
| Disease | ANEURYSM, INTRACRANIAL BERRY, 1 (disorder) | 4.43e-04 | 6 | 162 | 2 | C1862932 | |
| Disease | Hyalinosis, Segmental Glomerular | 4.81e-04 | 28 | 162 | 3 | C0086432 | |
| Disease | tonsillectomy risk measurement | 6.08e-04 | 260 | 162 | 7 | EFO_0007924 | |
| Disease | arachidonate 15-lipoxygenase B measurement | 6.18e-04 | 7 | 162 | 2 | EFO_0801391 | |
| Disease | newborn respiratory distress syndrome (is_implicated_in) | 6.18e-04 | 7 | 162 | 2 | DOID:12716 (is_implicated_in) | |
| Disease | laurylcarnitine measurement | 6.18e-04 | 7 | 162 | 2 | EFO_0021041 | |
| Disease | Alzheimer's disease 1 (implicated_via_orthology) | 6.18e-04 | 7 | 162 | 2 | DOID:0080348 (implicated_via_orthology) | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 4 measurement | 8.21e-04 | 8 | 162 | 2 | EFO_0801768 | |
| Disease | Colorectal Neoplasms | 8.82e-04 | 277 | 162 | 7 | C0009404 | |
| Disease | Focal glomerulosclerosis | 1.02e-03 | 36 | 162 | 3 | C0017668 | |
| Disease | Hyperhomocysteinemia | 1.59e-03 | 11 | 162 | 2 | C0598608 | |
| Disease | complement C1q tumor necrosis factor-related protein 1 measurement | 1.91e-03 | 12 | 162 | 2 | EFO_0801493 | |
| Disease | granulins measurement | 1.91e-03 | 12 | 162 | 2 | EFO_0008141 | |
| Disease | Familial idiopathic steroid-resistant nephrotic syndrome | 2.25e-03 | 13 | 162 | 2 | cv:C4273714 | |
| Disease | Diverticular Bleeding | 2.25e-03 | 13 | 162 | 2 | C4505353 | |
| Disease | Diverticular Diseases | 2.25e-03 | 13 | 162 | 2 | C4317009 | |
| Disease | iron deficiency anemia (biomarker_via_orthology) | 2.25e-03 | 13 | 162 | 2 | DOID:11758 (biomarker_via_orthology) | |
| Disease | platelet crit | KIF26A MYO9B LAMA5 ZGPAT TRAFD1 NCAN MARK4 DCHS1 PJA1 CBX8 NOTCH3 SMIM44 SMG6 | 2.37e-03 | 952 | 162 | 13 | EFO_0007985 |
| Disease | Hamman-Rich syndrome | 2.61e-03 | 14 | 162 | 2 | C0085786 | |
| Disease | Impaired cognition | 2.61e-03 | 14 | 162 | 2 | C0338656 | |
| Disease | bacterial pneumonia (biomarker_via_orthology) | 2.61e-03 | 14 | 162 | 2 | DOID:874 (biomarker_via_orthology) | |
| Disease | FEV/FEC ratio | MAP2 ZKSCAN2 ARHGEF17 TGFBR3 DLC1 SFTPA2 ANKRD11 LMOD1 SFTPA1 ELN PJA1 TNXB D2HGDH SMIM44 SMG6 | 3.24e-03 | 1228 | 162 | 15 | EFO_0004713 |
| Disease | Hepatomegaly | 3.28e-03 | 54 | 162 | 3 | C0019209 | |
| Disease | Peripheral Nervous System Diseases | 3.28e-03 | 54 | 162 | 3 | C4721453 | |
| Disease | Glioblastoma Multiforme | 3.32e-03 | 111 | 162 | 4 | C1621958 | |
| Disease | Cardiovascular Abnormalities | 3.42e-03 | 16 | 162 | 2 | C0243050 | |
| Disease | immature platelet fraction | 3.66e-03 | 114 | 162 | 4 | EFO_0009187 | |
| Disease | physical activity measurement, body mass index | 3.66e-03 | 114 | 162 | 4 | EFO_0004340, EFO_0008002 | |
| Disease | Dementia | 3.86e-03 | 17 | 162 | 2 | C0497327 | |
| Disease | muscular dystrophy (is_implicated_in) | 3.86e-03 | 17 | 162 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | urate measurement | COL7A1 DPYSL5 ZKSCAN2 VARS2 APP TP53INP2 GRAMD4 ZNHIT6 GLI1 SPIN1 NINL SMIM44 | 4.00e-03 | 895 | 162 | 12 | EFO_0004531 |
| Disease | urate measurement, spine bone mineral density | 4.02e-03 | 58 | 162 | 3 | EFO_0004531, EFO_0007701 | |
| Disease | venous thromboembolism | 4.03e-03 | 460 | 162 | 8 | EFO_0004286 | |
| Disease | diastolic blood pressure, systolic blood pressure | CNTROB TP53INP2 CREB5 KIAA1671 DLC1 CLCA2 ADAMTS15 MLN ELN CPNE7 | 4.04e-03 | 670 | 162 | 10 | EFO_0006335, EFO_0006336 |
| Disease | Feeding difficulties | 4.33e-03 | 18 | 162 | 2 | C0232466 | |
| Disease | X-11470 measurement | 4.82e-03 | 19 | 162 | 2 | EFO_0021241 | |
| Disease | chronic obstructive pulmonary disease (is_implicated_in) | 5.07e-03 | 63 | 162 | 3 | DOID:3083 (is_implicated_in) | |
| Disease | angina pectoris | 5.07e-03 | 125 | 162 | 4 | EFO_0003913 | |
| Disease | Familial Idiopathic Pulmonary Fibrosis | 5.33e-03 | 20 | 162 | 2 | C4721952 | |
| Disease | basophil count | 5.38e-03 | 483 | 162 | 8 | EFO_0005090 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RDGSVPLPESTRELG | 101 | Q8WZ19 | |
| EDRIDEPDGLGPRRS | 306 | Q86US8 | |
| TEKREIPPGIERGAE | 826 | Q5RHP9 | |
| GAPLGLRLPRETDEE | 36 | P56817 | |
| DGSIVIPPSEVEGRD | 606 | P48751 | |
| EETGRREISPEENGP | 1146 | A6H8Y1 | |
| AELEEVGPSRRVGEE | 1761 | A6H8Y1 | |
| VEAETVPEERARGDP | 2221 | Q6UB99 | |
| RAVAVKEEPRGPEGS | 116 | Q15744 | |
| GELRPEVVEDEVPRS | 16 | Q7L8J4 | |
| EVEPVDARPAADRGL | 636 | P05067 | |
| RERVLPPEVADGGVV | 391 | P56945 | |
| VAGPGREPLELEVAV | 446 | P56945 | |
| EEEEESIAAVPGRRG | 1056 | Q9UIF9 | |
| SGTIRQGEELPPEEL | 201 | Q12774 | |
| EAPGTGKETAPERRE | 701 | Q14416 | |
| RDSEELRDPAGPGTL | 46 | Q6IC98 | |
| EARRESLDPVQEPGG | 196 | Q99674 | |
| PPAEERDVGRLREAL | 151 | Q9BU89 | |
| AGGSEPEREVVVPIR | 16 | Q8TE58 | |
| PTEGRPGIERLTAEF | 261 | Q69YU3 | |
| EREPPAILFRRAGGE | 671 | Q9HCE9 | |
| DGEDRPVRSRSEGPD | 81 | P10082 | |
| GYPEGVERIDEPGLR | 381 | P12955 | |
| EPVGSQEDGPRLRAV | 196 | O75154 | |
| SGEDEVLLGARPRPR | 281 | O15438 | |
| GEPTEPEIEARPRLA | 486 | O95907 | |
| PGLPGRRSAERALEE | 26 | O75427 | |
| GRDAVLRCEGPIPDV | 416 | P04217 | |
| PGLREEDTDTPGLRR | 26 | Q96PE2 | |
| LVEQRAEPEEPGATR | 866 | Q96PE2 | |
| PTGGRRRRVVDEDPD | 361 | Q02930 | |
| IPQPGEGDVREEALS | 111 | P49914 | |
| DKEGERLEGVAAPPR | 581 | O60500 | |
| GTPVPELVVTGELDR | 201 | Q96JQ0 | |
| DIDGLVPTRDERGQP | 431 | Q6ZVH7 | |
| GPVEGRDTAELPART | 391 | Q16849 | |
| AERVGPERGPLERET | 821 | Q14676 | |
| ESPSPRLGRGLELAE | 401 | Q9BY89 | |
| VADEVTRPRPSGEEV | 106 | P33992 | |
| PARGEPEVTVEIGET | 46 | Q9H7Z6 | |
| GPDDTPEEILARIGS | 621 | P51812 | |
| RVFSGRESPEPGEEE | 166 | Q96BY2 | |
| LDVVDPDGSVPVGLR | 36 | P29536 | |
| GTRIPLEVPVDEDVG | 151 | O95206 | |
| ELDVRAQDRGPGPRA | 321 | O95206 | |
| IGPVLPLEERGAETE | 161 | Q96M96 | |
| EEEAGRRAPEGPRSL | 31 | Q8N819 | |
| VLGPTGVAEPVEVRD | 1481 | Q14315 | |
| EPRARRELAPEVIGS | 1566 | Q9UM47 | |
| PRESRPAEVPAEGLV | 1226 | Q8N3D4 | |
| DLAGPEGSRRPEVEA | 161 | Q496M5 | |
| PAPEVEELARRLGEA | 171 | P48681 | |
| EPLRSPEVGDEEALR | 676 | P48681 | |
| PDLSPRIVDGIEDSG | 821 | Q9UQ05 | |
| GAAAVLRGEEEPRPS | 1391 | Q9ULI4 | |
| TVEPKREREGGPIRE | 411 | P08151 | |
| GPIREESRLTVPEGA | 421 | P08151 | |
| AGLGPERLSPEELVR | 11 | Q6P597 | |
| ATPGAPRIEQLDGVD | 2051 | Q9UMN6 | |
| VRGVLDLDRPGEPAG | 2331 | Q9UMN6 | |
| PGVRRTPEEAAAGEV | 711 | P0C869 | |
| PGATLPDVGLELEVR | 3536 | O15230 | |
| GDPVLRGVAAPVERA | 71 | Q9HBH1 | |
| EPGVRPCEVGLVVDT | 231 | P52790 | |
| EEEARRPRGEDGKPV | 946 | Q27J81 | |
| GGEPLIRPDVVDIVA | 126 | Q9NZB8 | |
| TPRDPGQEGELERAA | 316 | P0CG20 | |
| RALREAAGPVGPALE | 196 | O00459 | |
| LTENPAGLRGAVEEP | 111 | Q9BXP8 | |
| VTREDFLVGRPPELG | 276 | Q8N0W3 | |
| RIPVARILGDPEEES | 336 | Q9HC52 | |
| RPRPGVTEATITGLE | 2041 | P02751 | |
| LIPVDRAIEDTRPAG | 471 | Q7Z7M9 | |
| KEEREPAIALAPRGG | 1221 | Q4ZHG4 | |
| EPEGEAEDRVTAGPR | 1801 | Q8IZJ3 | |
| DDGVLRSPRGEPALR | 561 | Q9UBL6 | |
| PPGGLRIEDIRATSV | 606 | Q12860 | |
| GEDLAVGAPPRGEVI | 941 | O75128 | |
| VGSRLPPGAERIALE | 766 | Q53R41 | |
| LELRPRGEAAEGPAA | 16 | O95390 | |
| GVRLSPEPGREGVRD | 21 | Q9NWK9 | |
| GILEERSPAFRGPDR | 316 | Q9H3Q1 | |
| RIIGVDPEGSILAEP | 276 | P35520 | |
| PERAEAVGETLTLPG | 266 | Q8NFZ8 | |
| ETVTLEDGRIGERPE | 451 | Q7Z388 | |
| RRLLEPGAAEPAERG | 26 | Q68DC2 | |
| PGIPAREELARETGL | 146 | Q96PT4 | |
| DVPQAEVGRGRREPA | 21 | Q8N6I1 | |
| REIPDRGPLGLESGD | 356 | Q9ULV5 | |
| RVADEPERIGGPEVT | 626 | Q96L34 | |
| GRQRLEERTGPAGPE | 41 | Q6P0Q8 | |
| AATPTLPRVEERRDG | 41 | Q9Y2Y9 | |
| REEGPAAVIVARTDP | 671 | Q02388 | |
| SGEEAARAIPRELPV | 151 | Q9Y4K1 | |
| EALTVAIRRPPDLGG | 671 | Q14689 | |
| ARGSEGRVEPKAEPV | 741 | Q7Z2K8 | |
| LLGTPGPEDEARAER | 156 | Q6ZMB0 | |
| IALERPDIDPGSTER | 1311 | O95180 | |
| GVRRSLSPELREGDP | 616 | P15502 | |
| PGRESRVEEPLENDI | 61 | Q9NV23 | |
| EEAIRISEDPARDGP | 2381 | P21817 | |
| ISEDPARDGPGIRRD | 2386 | P21817 | |
| EGESVTVLRRDGPEE | 781 | Q8WUF5 | |
| TGEETVRLGFPVDPR | 171 | Q9Y597 | |
| PLIPGAGSERREEDS | 121 | Q8N137 | |
| ERIVPGGVVTDPEAL | 71 | Q8N465 | |
| TGPEGIEISRPEELE | 211 | Q9BPU6 | |
| DGPEAEAVREARVPL | 236 | P0CW18 | |
| EAEAGVAVEVRGLPP | 6 | Q53GL7 | |
| EPDSIERRPVKDGGG | 626 | P33527 | |
| LPEDIRTRGVEDIPG | 456 | O15296 | |
| GERPPLLGERRSAAE | 31 | Q9NP95 | |
| AEERAPSRRGLAEPG | 506 | Q16799 | |
| IDEAPQERLRETEGP | 141 | Q8IYJ3 | |
| LTGRPGAELTLERDP | 566 | Q5ST30 | |
| GDVDLTRLPEGPVDS | 216 | Q8TEU7 | |
| RPREENDLGPAGTVD | 266 | Q9NQ40 | |
| GREGEEKRNEVAIPP | 136 | O14545 | |
| REDVIPSGIPQAEDR | 3556 | Q8NF91 | |
| RREPEEPEGAVAARA | 436 | A6NKL6 | |
| PEVSRGEEGRISESP | 181 | Q9H4M7 | |
| GEPITLFGEGPAERR | 116 | O43172 | |
| RVRPVTKEDGEGPEA | 451 | Q9BVG8 | |
| TEPGIRRVPGASEVI | 541 | Q9HDB5 | |
| SSLEPRRPEEAGAEV | 41 | Q6ZNJ1 | |
| GPDRESLEGLEVAPR | 341 | Q9UL41 | |
| EGEILSAEGPPVREL | 376 | O14594 | |
| GRVPEGRALDSEVDP | 336 | Q6IA17 | |
| PADAPGRARILVEES | 26 | P61647 | |
| PREELPSAVRAEEGQ | 946 | Q13796 | |
| RAPERELGTGEQPLS | 626 | Q96NU1 | |
| RRPARPLELDSGGEE | 1021 | Q9UPS6 | |
| EAIPPGPRGRDEVTE | 1616 | Q9UPS6 | |
| ENLVRSVPSGEPGRE | 41 | Q6UW49 | |
| EAPPGEELEPRTRVG | 126 | Q8TC41 | |
| ARAGGRIAVPRNPEE | 156 | Q8IWL1 | |
| RREERAEVGAPLSPD | 551 | P23327 | |
| PGARELPLLGTERDA | 936 | Q9Y2I6 | |
| EPSEIPERRDSGVGA | 976 | Q96QB1 | |
| LTKVEGEERPRDSPG | 21 | Q8IY50 | |
| ARAGGRIAVPRNPEE | 156 | Q8IWL2 | |
| TSALDRGGRVPLPIE | 176 | Q16586 | |
| GGAVAELEPRPTRRE | 1071 | P36956 | |
| ESAVVGSPDPIRGEV | 496 | Q08AH1 | |
| TAEDPGARERGPDLL | 206 | E9PGG2 | |
| GPVEARVTFVDPRDL | 601 | Q8IUL8 | |
| RSPAEAEARGPEGLL | 31 | P0C7M8 | |
| PETGDPVTLRLLDDG | 646 | Q9UQC9 | |
| PLPEEGEERRRLGAE | 576 | Q5TCY1 | |
| RATDGPGEAVALPRL | 416 | P17040 | |
| EPEAGGTRAPEERSR | 1556 | Q9C0A1 | |
| EELVEAPRAQGDRGP | 701 | Q9NZQ8 | |
| ERRGLFGVPELSAPE | 61 | Q99797 | |
| RSGEEGPVDPAEPIR | 56 | P12872 | |
| PDGDLSEGELTPARR | 131 | Q8IXH6 | |
| PAEREPGEVVDSLVG | 201 | Q9Y657 | |
| RALEPPAEDRGDEVV | 476 | Q9P227 | |
| RPREGPEAELGSSRV | 926 | Q9P2H5 | |
| APEDLRRVSEPDLTG | 251 | Q9BX66 | |
| PVEGSLREVSVPGLD | 1821 | P22105 | |
| PAERRGLEELEVPVD | 161 | Q9NRS6 | |
| VAPPEDLRVAGISDR | 326 | Q92752 | |
| PRELRPSLTGEDLEG | 81 | A0A286YF18 | |
| VVKREPAEQPGDGER | 291 | Q14151 | |
| RVVAEPGLDVPEGAA | 1446 | Q9BZZ2 | |
| TRETAVPGPLGIEDI | 1411 | Q12888 | |
| SILPPRRGVSGDRDE | 1546 | P11137 | |
| VVGETEAPGVRPDPR | 311 | Q3C1V9 | |
| AIGDVVEGRPELTPI | 356 | Q9NNW7 | |
| RVGELPEVTELVSGP | 21 | Q8N9X3 | |
| EEVPSPSRQERGGIE | 596 | Q63HK3 | |
| PAEETLELGRLVSPG | 66 | Q9ULZ0 | |
| SEEEGAGPVERPPVR | 126 | Q8NG27 | |
| EGDGILPPLRTEATE | 261 | Q8N5A5 | |
| PGLREPEEVQGSVDI | 436 | Q03167 | |
| ELRAEITGPDGTRLP | 361 | O75382 | |
| LDDTRPGDGRRVTPL | 236 | A6NMK8 | |
| TGREEGLEVGPPEVL | 421 | Q13459 |